{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:01:48Z","timestamp":1789603308839,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["45\/29\/2022-BIO\/BMS"],"award-info":[{"award-number":["45\/29\/2022-BIO\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["02\/(0354)\/19\/EMRII"],"award-info":[{"award-number":["02\/(0354)\/19\/EMRII"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MoE STARS, IISc Bangolre","award":["STARS2\/2023-0040"],"award-info":[{"award-number":["STARS2\/2023-0040"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11030-024-10820-0","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T13:01:49Z","timestamp":1712235709000},"page":"4361-4380","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Identification of potential JNK3 inhibitors through virtual screening, molecular docking and molecular dynamics simulation as therapeutics for Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"28","author":[{"given":"Bharti","family":"Devi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailash","family":"Jangid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1438-9438","authenticated-orcid":false,"given":"Vinod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,4]]},"reference":[{"issue":"11","key":"10820_CR1","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1021\/bi992410+","volume":"39","author":"J Lisnock","year":"2000","unstructured":"Lisnock J, Griffin P, Calaycay J, Frantz B, Parsons J, O\u2019Keefe SJ, LoGrasso P (2000) Activation of JNK3 alpha 1 requires both MKK4 and MKK7: kinetic characterization of in vitro phosphorylated JNK3 alpha 1. Biochemistry 39(11):3141\u20133148","journal-title":"Biochemistry"},{"issue":"5","key":"10820_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.4161\/cc.3.5.888","volume":"3","author":"T Wada","year":"2004","unstructured":"Wada T, Penninger JM (2004) Stress kinase MKK7: saviour of cell cycle arrest and cellular senescence. Cell Cycle 3(5):575\u2013577","journal-title":"Cell Cycle"},{"key":"10820_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1042\/bj3520145","volume":"352","author":"Y Fleming","year":"2000","unstructured":"Fleming Y, Armstrong CG, Morrice N, Paterson A, Goedert M, Cohen P (2000) Synergistic activation of stress-activated protein kinase 1\/c-Jun N-terminal kinase (SAPK1\/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7. Biochem J 352:145\u2013154","journal-title":"Biochem J"},{"issue":"1","key":"10820_CR4","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1038\/s41467-019-11982-4","volume":"10","author":"S Kant","year":"2019","unstructured":"Kant S, Craige SM, Chen K, Reif MM, Learnard H, Kelly M, Caliz AD, Tran K-V, Ramo K, Peters OM, Freeman M, Davis RJ, Keaney JF (2019) Neural JNK3 regulates blood flow recovery after hindlimb ischemia in mice via an Egr1\/Creb1 axis. Nat Commun 10(1):4223","journal-title":"Nat Commun"},{"key":"10820_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fphar.2015.00321","volume":"6","author":"R Yarza","year":"2016","unstructured":"Yarza R, Vela S, Solas M, Ramirez MJ (2016) c-Jun N-terminal kinase (JNK) signaling as a therapeutic target for Alzheimer\u2019s disease. Front Pharmacol 6:321","journal-title":"Front Pharmacol"},{"issue":"4","key":"10820_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1021\/ml500474d","volume":"6","author":"K Zheng","year":"2015","unstructured":"Zheng K, Park CM, Iqbal S, Hernandez P, Park H, LoGrasso PV, Feng Y (2015) Pyridopyrimidinone derivatives as potent and selective c-Jun N-terminal kinase (JNK) inhibitors. ACS Med Chem Lett 6(4):413\u2013418","journal-title":"ACS Med Chem Lett"},{"issue":"10","key":"10820_CR7","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.3390\/cells9102190","volume":"9","author":"CA Musi","year":"2020","unstructured":"Musi CA, Agr\u00f2 G, Santarella F, Iervasi E, Borsello T (2020) JNK3 as therapeutic target and biomarker in neurodegenerative and neurodevelopmental brain diseases. Cells 9(10):2190","journal-title":"Cells"},{"issue":"23","key":"10820_CR8","doi-asserted-by":"publisher","first-page":"15903","DOI":"10.1074\/jbc.M710006200","volume":"283","author":"C Guo","year":"2008","unstructured":"Guo C, Whitmarsh AJ (2008) The \u03b2-arrestin-2 scaffold protein promotes c-Jun N-terminal kinase-3 activation by binding to its nonconserved N terminus. J Biol Chem 283(23):15903\u201315911","journal-title":"J Biol Chem"},{"issue":"2","key":"10820_CR9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1471-4159.2004.02479.x","volume":"90","author":"H Yoshida","year":"2004","unstructured":"Yoshida H, Hastie CJ, McLauchlan H, Cohen P, Goedert M (2004) Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK). J Neurochem 90(2):352\u2013358","journal-title":"J Neurochem"},{"key":"10820_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111696","volume":"140","author":"M Wang","year":"2021","unstructured":"Wang M, Hayashi H, Horinokita I, Asada M, Iwatani Y, Liu J-X, Takagi N (2021) Neuroprotective effects of Senkyunolide I against glutamate-induced cells death by attenuating JNK\/caspase-3 activation and apoptosis. Biomed Pharmacother 140:111696","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10820_CR11","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.neuron.2012.06.024","volume":"75","author":"SO Yoon","year":"2012","unstructured":"Yoon SO, Park DJ, Ryu JC, Ozer HG, Tep C, Shin YJ, Lim TH, Pastorino L, Kunwar AJ, Walton JC, Nagahara AH (2012) JNK3 perpetuates metabolic stress induced by A\u03b2 peptides. Neuron 75(5):824\u2013837","journal-title":"Neuron"},{"issue":"25","key":"10820_CR12","doi-asserted-by":"publisher","first-page":"15184","DOI":"10.1073\/pnas.2336254100","volume":"100","author":"CY Kuan","year":"2003","unstructured":"Kuan CY, Whitmarsh AJ, Yang DD, Liao G, Schloemer AJ, Dong C, Bao J, Banasiak KJ, Haddad GG, Flavell RA, Davis RJ, Rakic P (2003) A critical role of neural-specific JNK3 for ischemic apoptosis. Proc Natl Acad Sci USA 100(25):15184\u201315189","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10820_CR13","first-page":"4437","volume":"55","author":"L de Lemos","year":"2018","unstructured":"de Lemos L, Junyent F, Camins A, Castro-Torres RD, Folch J, Olloquequi J, Beas-Zarate C, Verdaguer E, Auladell C (2018) Neuroprotective effects of the absence of JNK1 or JNK3 isoforms on kainic acid-induced temporal lobe epilepsy-like symptoms. Mol Neurobiol 55(5):4437\u20134452","journal-title":"Mol Neurobiol"},{"issue":"55","key":"10820_CR14","doi-asserted-by":"publisher","first-page":"8950","DOI":"10.1038\/sj.onc.1208015","volume":"23","author":"A Sevilla","year":"2004","unstructured":"Sevilla A, Santos CR, Barcia R, Vega FM, Lazo PA (2004) c-Jun phosphorylation by the human vaccinia-related kinase 1 (VRK1) and its cooperation with the N-terminal kinase of c-Jun (JNK). Oncogene 23(55):8950\u20138958","journal-title":"Oncogene"},{"issue":"9","key":"10820_CR15","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nrc883","volume":"2","author":"S Cory","year":"2002","unstructured":"Cory S, Adams JM (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2(9):647\u2013656","journal-title":"Nat Rev Cancer"},{"key":"10820_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.106090","volume":"128","author":"P Qin","year":"2022","unstructured":"Qin P, Ran Y, Liu Y, Wei C, Luan X, Niu H, Peng J, Sun J, Wu J (2022) Recent advances of small molecule JNK3 inhibitors for Alzheimer\u2019s disease. Bioorg Chem 128:106090","journal-title":"Bioorg Chem"},{"key":"10820_CR17","doi-asserted-by":"crossref","unstructured":"Godieva V, Sammoura F, Paz SV, Han Y, Guida VD, Rishel MJ, Richardson JR, Chambers JW (2024) Physiological JNK3 Concentrations Are Higher in Motor-related and Disease-implicated Brain Regions of C57BL6\/J Mice. bioRxiv","DOI":"10.1101\/2024.01.17.575386"},{"issue":"6","key":"10820_CR18","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10822-020-00297-y","volume":"34","author":"RK Rajan","year":"2020","unstructured":"Rajan RK, Ramanathan M (2020) Identification and neuroprotective evaluation of a potential c-Jun N-terminal kinase 3 inhibitor through structure-based virtual screening and in-vitro assay. J Comput Aided Mol Des 34(6):671\u2013682","journal-title":"J Comput Aided Mol Des"},{"issue":"3","key":"10820_CR19","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.bmcl.2011.12.027","volume":"22","author":"VP Krenitsky","year":"2012","unstructured":"Krenitsky VP, Nadolny L, Delgado M, Ayala L, Clareen SS, Hilgraf R, Albers R, Hegde S, D\u2019Sidocky N, Sapienza J, Wright J (2012) Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor. Bioorg Med Chem Lett 22(3):1433\u20131438","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10820_CR20","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1080\/14756366.2020.1720013","volume":"35","author":"Q Wu","year":"2020","unstructured":"Wu Q, Wu W, Jacevic V, Franca TC, Wang X, Kuca K (2020) Selective inhibitors for JNK signalling: a potential targeted therapy in cancer. J Enzyme Inhibit Med Chem 35(1):574\u2013583","journal-title":"J Enzyme Inhibit Med Chem"},{"issue":"1","key":"10820_CR21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00210-023-02616-0","volume":"397","author":"RK Rajan","year":"2024","unstructured":"Rajan RK, Kumar RP, Ramanathan M (2024) Piceatannol improved cerebral blood flow and attenuated JNK3 and mitochondrial apoptotic pathway in a global ischemic model to produce neuroprotection. Naunyn Schmiedebergs Arch Pharmacol 397(1):479\u2013496","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"14","key":"10820_CR22","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1021\/acschemneuro.2c00132","volume":"13","author":"B Kumar","year":"2022","unstructured":"Kumar B, Dwivedi AR, Arora T, Raj K, Prashar V, Kumar V, Singh S, Prakash J, Kumar V (2022) Design, Synthesis, and pharmacological evaluation of N-propargylated diphenylpyrimidines as multitarget directed ligands for the treatment of Alzheimer\u2019s Disease. ACS Chem Neurosci 13(14):2122\u20132139","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"10820_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1021\/acschemneuro.8b00220","volume":"10","author":"B Kumar","year":"2019","unstructured":"Kumar B, Dwivedi AR, Sarkar B, Gupta SK, Krishnamurthy S, Mantha AK, Parkash J, Kumar V (2019) 4,6-Diphenylpyrimidine derivatives as dual inhibitors of monoamine oxidase and acetylcholinesterase for the treatment of Alzheimer\u2019s disease. ACS Chem Neurosci 10(1):252\u2013265","journal-title":"ACS Chem Neurosci"},{"issue":"7","key":"10820_CR24","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/cmdc.201700589","volume":"13","author":"B Kumar","year":"2018","unstructured":"Kumar B, Kumar M, Dwivedi AR, Kumar V (2018) Synthesis, biological evaluation and molecular modeling studies of propargyl-containing 2, 4, 6-Trisubstituted pyrimidine derivatives as potential anti-Parkinson agents. ChemMedChem 13(7):705\u2013712","journal-title":"ChemMedChem"},{"key":"10820_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ejmech.2019.05.039","volume":"177","author":"B Kumar","year":"2019","unstructured":"Kumar B, Kumar V, Prashar V, Saini S, Dwivedi AR, Bajaj B, Mehta D, Parkash J, Kumar V (2019) Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase. Eur J Med Chem 177:221\u2013234","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10820_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2174\/1389450117666151209123402","volume":"18","author":"B Kumar","year":"2017","unstructured":"Kumar B, Prakash Gupta V, Kumar V (2017) A perspective on monoamine oxidase enzyme as drug target: challenges and opportunities. Curr Drug Targets 18(1):87\u201397","journal-title":"Curr Drug Targets"},{"issue":"22","key":"10820_CR27","doi-asserted-by":"publisher","first-page":"5095","DOI":"10.1016\/j.bmcl.2005.06.083","volume":"15","author":"B-M Swahn","year":"2005","unstructured":"Swahn B-M, Huerta F, Kallin E, Malmstr\u00f6m J, Weigelt T, Viklund J, Womack P, Xue Y, \u00d6hberg L (2005) Design and synthesis of 6-anilinoindazoles as selective inhibitors of c-Jun N-terminal kinase-3. Bioorg Med Chem Lett 15(22):5095\u20135099","journal-title":"Bioorg Med Chem Lett"},{"key":"10820_CR28","unstructured":"Wizard, P. P.; Epik, S.; Prime, L.; Glide, S. J. N. Y., NY, LLC. 2021, 34."},{"key":"10820_CR29","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","volume":"21","author":"JC Shelley","year":"2007","unstructured":"Shelley JC, Cholleti A, Frye LL, Greenwood JR, Timlin MR, Uchimaya M (2007) Epik: a software program for pK a prediction and protonation state generation for drug-like molecules. J Comput-Aided Mol Des 21:681\u2013691","journal-title":"J Comput-Aided Mol Des"},{"issue":"7","key":"10820_CR30","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","volume":"17","author":"C Lu","year":"2021","unstructured":"Lu C, Wu C, Ghoreishi D, Chen W, Wang L, Damm W, Ross GA, Dahlgren MK, Russell E, Von Bargen CD, Abel R (2021) OPLS4: Improving force field accuracy on challenging regimes of chemical space. J Chem Theory Comput 17(7):4291\u20134300","journal-title":"J Chem Theory Comput"},{"issue":"1","key":"10820_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/0471250953.bi0812s18","volume":"18","author":"MP Repasky","year":"2007","unstructured":"Repasky MP, Shelley M, Friesner RA (2007) Flexible ligand docking with Glide. Curr Protoc Bioinform 18(1):8\u201312","journal-title":"Curr Protoc Bioinform"},{"issue":"1","key":"10820_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1021\/acschembio.7b00903","volume":"13","author":"JB Baell","year":"2018","unstructured":"Baell JB, Nissink JWM (2018) Seven year itch: Pan-assay interference compounds (PAINS) in 2017 utility and limitations. ACS Chem Biol 13(1):36\u201344","journal-title":"ACS Chem Biol"},{"key":"10820_CR33","first-page":"31","volume":"8","author":"G Landrum","year":"2013","unstructured":"Landrum G (2013) RDKit: a software suite for cheminformatics, computational chemistry, and predictive modeling. Greg Landrum 8:31","journal-title":"Greg Landrum"},{"issue":"1","key":"10820_CR34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1145\/1656274.1656280","volume":"11","author":"MR Berthold","year":"2009","unstructured":"Berthold MR, Cebron N, Dill F, Gabriel TR, K\u00f6tter T, Meinl T, Ohl P, Thiel K, Wiswedel B (2009) KNIME-the Konstanz information miner: version 2.0 and beyond. AcM SIGKDD Explor Newslett 11(1):26\u201331","journal-title":"AcM SIGKDD Explor Newslett"},{"issue":"2","key":"10820_CR35","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1021\/ci800293n","volume":"49","author":"KE Hevener","year":"2009","unstructured":"Hevener KE, Zhao W, Ball DM, Babaoglu K, Qi J, White SW, Lee RE (2009) Validation of molecular docking programs for virtual screening against dihydropteroate synthase. J Chem Inform Model 49(2):444\u2013460","journal-title":"J Chem Inform Model"},{"key":"10820_CR36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10822-007-9163-6","volume":"22","author":"J Kirchmair","year":"2008","unstructured":"Kirchmair J, Markt P, Distinto S, Wolber G, Langer T (2008) Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection\u2014what can we learn from earlier mistakes? J Comput-Aided Mol Des 22:213\u2013228","journal-title":"J Comput-Aided Mol Des"},{"issue":"14","key":"10820_CR37","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger MM, Carchia M, Irwin JJ, Shoichet BK (2012) Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem 55(14):6582\u20136594","journal-title":"J Med Chem"},{"key":"10820_CR38","doi-asserted-by":"crossref","unstructured":"Gaulton A, Hersey A, Nowotka M, Bento AP, Chambers J, Mendez D, Mutowo P, Atkinson F, Bellis LJ, Cibri\u00e1n-Uhalte EJN (2017) The ChEMBL database in 2017. 45 (D1), D945-D954.","DOI":"10.1093\/nar\/gkw1074"},{"issue":"16","key":"10820_CR39","doi-asserted-by":"publisher","first-page":"7835","DOI":"10.1080\/07391102.2022.2126397","volume":"41","author":"A Biharee","year":"2023","unstructured":"Biharee A, Yadav A, Jangid K, Singh Y, Kulkarni S, Sawant DM, Kumar P, Thareja S, Jain AK (2023) Flavonoids as promising anticancer agents: an in silico investigation of ADMET, binding affinity by molecular docking and molecular dynamics simulations. J Biomol Struct Dyn 41(16):7835\u20137846","journal-title":"J Biomol Struct Dyn"},{"issue":"16","key":"10820_CR40","doi-asserted-by":"publisher","first-page":"7683","DOI":"10.1021\/acs.jmedchem.6b00356","volume":"59","author":"SN Dighe","year":"2016","unstructured":"Dighe SN, Deora GS, De la Mora E, Nachon F, Chan S, Parat MO, Brazzolotto X, Ross BP (2016) Discovery and structure\u2013activity relationships of a highly selective butyrylcholinesterase inhibitor by structure-based virtual screening. J Med Chem 59(16):7683\u20137689","journal-title":"J Med Chem"},{"key":"10820_CR41","unstructured":"Release SJS (2019) LLC, New York, 4: LigPrep."},{"issue":"15","key":"10820_CR42","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1002\/jcc.20111","volume":"25","author":"B Kuhn","year":"2004","unstructured":"Kuhn B, Kollman PA, Stahl M (2004) Prediction of pKa shifts in proteins using a combination of molecular mechanical and continuum solvent calculations. J Comput Chem 25(15):1865\u20131872","journal-title":"J Comput Chem"},{"issue":"7","key":"10820_CR43","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","volume":"17","author":"C Lu","year":"2021","unstructured":"Lu C, Wu C, Ghoreishi D, Chen W, Wang L, Damm W, Ross GA, Dahlgren MK, Russell E, Von Bargen CD (2021) OPLS4: improving force field accuracy on challenging regimes of chemical space. J Chem Theory Comput 17(7):4291\u20134300","journal-title":"J Chem Theory Comput"},{"key":"10820_CR44","unstructured":"QikProp S (2019) LLC. New York"},{"issue":"1","key":"10820_CR45","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/07391102.2023.2201838","volume":"42","author":"K Jangid","year":"2024","unstructured":"Jangid K, Devi B, Sahoo A, Kumar V, Dwivedi AR, Thareja S, Kumar R, Kumar V (2024) Virtual screening and molecular dynamics simulation approach for the identification of potential multi-target directed ligands for the treatment of Alzheimer\u2019s disease. J Biomol Struct Dyn 42(1):509\u2013527","journal-title":"J Biomol Struct Dyn"},{"key":"10820_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-023-10608-8","author":"B Devi","year":"2023","unstructured":"Devi B, Vasishta SS, Das B, Baidya AT, Rampa RS, Mahapatra MK, Kumar R (2023) Integrated use of ligand and structure-based virtual screening, molecular dynamics, free energy calculation and ADME prediction for the identification of potential PTP1B inhibitors. Mol Diversity. https:\/\/doi.org\/10.1007\/s11030-023-10608-8","journal-title":"Mol Diversity"},{"key":"10820_CR47","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2023.2256876","author":"A Das","year":"2023","unstructured":"Das A, Sarangi M, Jangid K, Kumar V, Kumar A, Singh PP, Kaur K, Kumar V, Chakraborty S, Jaitak V (2023) Identification of 1, 3, 4-oxadiazoles as tubulin-targeted anticancer agents: a combined field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, molecular dynamics simulation, and density functional theory calculation approach. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2023.2256876","journal-title":"J Biomol Struct Dyn"},{"issue":"10","key":"10820_CR48","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco MS, Vald\u00e9s-Tresanco ME, Valiente PA, Moreno E (2021) gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. J Chem Theory Comput 17(10):6281\u20136291","journal-title":"J Chem Theory Comput"},{"key":"10820_CR49","unstructured":"Landrum, G., Rdkit: Open-source cheminformatics software. 2016."},{"key":"10820_CR50","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1815584","author":"C Shivanika","year":"2020","unstructured":"Shivanika C, Kumar D, Ragunathan V, Tiwari P, Sumitha A (2020) Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1815584","journal-title":"J Biomol Struct Dyn"},{"key":"10820_CR51","first-page":"203","volume-title":"Proteinkinase Inhibitors","author":"P Koch","year":"2021","unstructured":"Koch P (2021) Inhibitors of c-Jun N-Terminal Kinase 3. In: Laufer S (ed) Proteinkinase Inhibitors. Springer International Publishing, Cham, pp 203\u2013224"},{"issue":"11","key":"10820_CR52","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.chembiol.2014.09.007","volume":"21","author":"A Messoussi","year":"2014","unstructured":"Messoussi A, Feneyrolles C, Bros A, Deroide A, Dayd\u00e9-Cazals B, Chev\u00e9 G, Van Hijfte N, Fauvel B, Bougrin K, Yasri A (2014) Recent Progress in the Design, Study, and Development of c-Jun N-Terminal Kinase Inhibitors as Anticancer Agents. Chem Biol 21(11):1433\u20131443","journal-title":"Chem Biol"},{"issue":"1","key":"10820_CR53","doi-asserted-by":"publisher","first-page":"9435","DOI":"10.1038\/s41598-018-27867-3","volume":"8","author":"P Mishra","year":"2018","unstructured":"Mishra P, G\u00fcnther S (2018) New insights into the structural dynamics of the kinase JNK3. Sci Rep 8(1):9435","journal-title":"Sci Rep"},{"key":"10820_CR54","doi-asserted-by":"crossref","unstructured":"Xie, X.; Gu, Y.; Fox, T.; Coll, J. T.; Fleming, M. A.; Markland, W.; Caron, P. R.; Wilson, K. P.; Su, M. S., Crystal structure of JNK3: a kinase implicated in neuronal apoptosis. Structure (London, England : 1993) 1998, 6 (8), 983\u201391.","DOI":"10.1016\/S0969-2126(98)00100-2"},{"key":"10820_CR55","unstructured":"Release, S., 4: LigPrep. Schr\u00f6dinger, LLC, New York, NY 2019."},{"key":"10820_CR56","unstructured":"Maestro, S., Maestro. Schr\u00f6dinger, LLC, New York, NY 2020, 2020."},{"issue":"14","key":"10820_CR57","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2174\/1568026616666161117112604","volume":"17","author":"X Zhang","year":"2017","unstructured":"Zhang X, Perez-Sanchez H, Lightstone FC (2017) A comprehensive docking and MM\/GBSA rescoring study of ligand recognition upon binding antithrombin. Curr Top Med Chem 17(14):1631\u20131639","journal-title":"Curr Top Med Chem"},{"issue":"5","key":"10820_CR58","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.drudis.2019.03.015","volume":"24","author":"LL Ferreira","year":"2019","unstructured":"Ferreira LL, Andricopulo AD (2019) ADMET modeling approaches in drug discovery. Drug Discov Today 24(5):1157\u20131165","journal-title":"Drug Discov Today"},{"key":"10820_CR59","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2301510","author":"S Nema","year":"2023","unstructured":"Nema S, Chaturvedi R, Verma K, Anvikar AR, Tiwari A, Bharti PK (2023) 2024 A computational strategy for systematic virtual screening of plasmodium falciparum heme detoxification protein inhibitors from the Drugbank database. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2301510","journal-title":"J Biomol Struct Dyn"},{"key":"10820_CR60","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2303386","author":"AA Rabaan","year":"2024","unstructured":"Rabaan AA, Almansour ZH, Al Bshabshe A, Halwani MA, Al-Subaie MF, Al Kaabi NA, Alshamrani SA, Alshehri AA, Nahari MH, Alqahtani AS (2024) 2024 Application of temperature-dependent and steered molecular dynamics simulation to screen anti-dengue compounds against Marburg virus. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2303386","journal-title":"J Biomol Struct Dyn"},{"key":"10820_CR61","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2024.2304679","author":"S Rajendrasozhan","year":"2024","unstructured":"Rajendrasozhan S, Ahmad I, Obaidur Rab S, Alshahrani MY, Abdullah Almuqri E, Ahmad Siddiqui J, Mushtaque M (2024) In-silico investigation of RPS6KB1 associated cancer inhibitor: a drug repurposing study. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2024.2304679","journal-title":"J Biomol Struct Dyn"},{"key":"10820_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2023.108695","volume":"127","author":"A Biharee","year":"2024","unstructured":"Biharee A, Singh Y, Kulkarni S, Jangid K, Kumar V, Jain AK, Thareja S (2024) An amalgamated molecular dynamic and Gaussian based 3D-QSAR study for the design of 2, 4-thiazolidinediones as potential PTP1B inhibitors. J Mol Graph Model 127:108695","journal-title":"J Mol Graph Model"},{"issue":"1","key":"10820_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsb.2023.108054","volume":"216","author":"FB da Silva","year":"2024","unstructured":"da Silva FB, Simien JM, Viegas RG, Haglund E, Leite VBP (2024) Exploring the folding landscape of leptin: Insights into threading pathways. J Struct Biol 216(1):108054","journal-title":"J Struct Biol"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10820-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-024-10820-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10820-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T17:08:04Z","timestamp":1734628084000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-024-10820-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,4]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10820"],"URL":"https:\/\/doi.org\/10.1007\/s11030-024-10820-0","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,4]]},"assertion":[{"value":"13 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors claim no competing financial interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}